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Available online 6 August 2011Background: The relationship between major depressive disorder (MDD) and dysthymia, a
form of chronic depression, is complex. The two conditions are highly comorbid and it is
unclear whether they are two separate disease entities. We investigated the extent to which
patients with dysthymia superimposed on major depression can be distinguished from those
with recurrent MDD.
Methods:We examined the clinical features in 1970 Han Chinese women with MDD (DSM-IV)
between 30 and 60 years of age across China. Logistic regression was used to determine the
association between clinical features of MDD and dysthymia and between dysthymia and
disorders comorbid with major depression.
Results: The 354 cases with dysthymia had more severe MDD than those without, with more
episodes of MDD and greater co-morbidity for anxiety disorders. Patients with dysthymia had
higher neuroticism scores andweremore likely to have a family history of MDD. Theywere also
more likely to have suffered serious life events.
Limitations: Results were obtained in a clinically ascertained sample of Chinese women and
may not generalize to community-acquired samples or to other populations. It is not possible to
determine whether the associations represent causal relationships.
Conclusions: The additional diagnosis of dysthymia in Chinese women with recurrent MDD
defines a meaningful and potentially important subtype. We conclude that in some
circumstances it is possible to distinguish double depression from recurrent MDD.
© 2011 Elsevier B.V. Open access under CC BY license.Keywords:
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Comorbidity1. Introduction
Major depressive disorder (MDD) and dysthymia are two
common psychiatric disorders where the clinical presenta-
tion is typically dominated by a dysphoric mood. While MDD
is typically episodic, and durations can be as short as two
weeks, dysthymia is a formof chronic depression characterized
bydepressedmoodmoredays thannot, and symptoms that last
two years or more. Dysthymic patients tend to have a
ﬂuctuating course (Akiskal et al., 1980) and often have a
superimposed episode of MDD, a phenomenon called double
depression (DD) (Keller and Shapiro, 1982). Dysthymia affects
approximately 3% of the adult population (Weissman et al.,
1988) and has a prevalence of about 36% of outpatients in
mental health settings (Markowitz et al., 1992).
The relationship between dysthymia andMDD is complex.
The two conditions are highly comorbid (Markowitz et al.,
1992; Weissman et al., 1988) and it remains unclear whether
the two conditions reﬂect two separate disease entities or
different aspects of a single condition (Coryell et al., 1994;
Keller et al., 1995; Spalletta et al., 1996). Some distinctions
have been made: dysthymia and DD differ from MDD in that
they have poorer outcomes in naturalistic follow-up studies
(Klein et al., 2000), greater Axes I and II comorbidity
(Markowitz et al., 1992) and are more likely to have a family
history of mood and personality disorders (Klein et al., 1988,
1995; Riso et al., 1996). Few studies have systematically
examined, in European populations, differences in patients
with recurrent MDD without a history of dysthymia and DD.
In this report, we examine a large sample of carefully
assessed Han Chinese women with recurrent major depres-
sion, to determine if the clinical course and pattern of
comorbidity differ in those with and without a history of
dysthymia. To our knowledge, this is the ﬁrst time these
questions have been addressed in data from an East Asian
population. Compared to women with recurrent MDD
without a history of dysthymia, we expected DD patients to
exhibit a higher level of depressive symptomatology, anearlier onset of depression, higher rates of familial aggrega-
tion and greater comorbidity especially with anxiety disor-
ders (Kasch and Klein, 1996; Weissman et al., 1984).2. Methods
2.1. Subjects
Data for the present study draws upon the ongoing China,
OxfordandVCUExperimentalResearchonGeneticEpidemiology
(CONVERGE) studyofMDD. These analyseswere basedona total
of 1970 cases recruited from 53 provincial mental health centers
and psychiatric departments of general medical hospitals in 41
cities in 19 provinces and four central cities: Beijing, Shanghai,
Tianjin and Chongqing and 2597 controls who were recruited
from patients undergoing minor surgical procedures at general
hospitals or from local community centers. All cases and controls
were female and had four Han Chinese grandparents. Cases and
controls were excluded if they had a pre-existing history of
bipolar disorder, any type of psychosis or mental retardation.
Caseswere agedbetween30and60, had twoormoreepisodes of
MDD, with the ﬁrst episode occurring between 14 and 50 and
had not abused drug or alcohol before the ﬁrst episode of MDD.
Controlswere chosen tomatch the region of origin of cases,were
aged between 40 and 60, had never experienced an episode of
MDDandwere not blood relatives of cases. An olderminimal age
of controlswasused to reduce the chances that theymighthave a
subsequent ﬁrst onset of MDD. The mean age (and SD) of cases
and controls in the dataset was respectively 45.1 (8.8) and 47.7
(5.5).
All subjects were interviewed using a computerized
assessment system, which lasted on average two hours for a
case and one hour for a control. All interviewers were trained
by the CONVERGE team for aminimum of oneweek in the use
of the interview. The interview includes assessment of
psychopathology, demographic and personal characteristics,
and psychosocial functioning. Interviews were tape-recorded
Table 1
Relationship between six clinical features of major depressive disorder and
dysthymia.
Clinical feature of MDD P-value OR 95% CI
Age of onset b0.0001 0.96 0.94–0.97
Duration of longest episode b0.0001 1.04 1.01–1.05
Number of episodes of MD b0.0001 1.03 1.02–1.03
SLE (number of episodes) b0.0001 1.24 1.16–1.33
Family history of MD 0.0002 1.27 1.12–1.45
Neuroticism b0.0001 1.12 1.09–1.15
MDD: Major depressive disorder. SLE: Stressful life events. OR: Odds ratio
95% CI: 95% Conﬁdence intervals.
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who provided feedback on the quality of the interviews. The
study protocol was approved centrally by the Ethical Review
Board of Oxford University and the ethics committee in
participating hospitals in China.
2.2. Measures
The diagnoses of depressive (Dysthymia and Major
Depressive Disorder) and anxiety disorders (Generalized
AnxietyDisorder, Panic Disorderwith orwithout Agoraphobia)
were established with the Composite International Diagnostic
Interview (CIDI) (WHO lifetime version 2.1; Chinese version),
which classiﬁes diagnoses according to the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) criteria
(American Psychiatric Association, 1994).
The interviewwas originally translated intoMandarin by a
team of psychiatrists in Shanghai Mental Health Centre with
the translation reviewed and modiﬁed by members of the
CONVERGE team. Phobias, divided into ﬁve subtypes (animal,
situational, social and blood-injury, and agoraphobia) were
diagnosed using an adaptation of DSM-III criteria requiring
one or more unreasonable fears, including fears of different
animals, social phobia and agoraphobia that objectively
interfered with the respondent's life. The section on the
assessment of phobias was translated by the CONVERGE team
from the interview used in the Virginia Adult Twin Study of
Psychiatric and Substance Use Disorders (VATSPUD) (Kendler
and Prescott, 2006).
Additional information was collected using instruments
employed fromVATSPSUD, translated and reviewed for accuracy
by members of the CONVERGE team. The history of lifetime
major depression in the parents and siblings was assessed using
the Family History Research Diagnostic criteria (Endicott et al.,
1975). The stressful life events section, also developed for the
VATSPSUD study, assessed 16 traumatic lifetime events and the
age at their occurrence. Neuroticismwasmeasured with the 23-
item Eysenck Personality Questionnaire (Eysenck and Eysenck,
1975), which was also an established instrument for measuring
neuroticism.
Both the case and control interviews were fully comput-
erized into a bilingual system of Mandarin and English
developed in house in Oxford, and called SysQ. Skip patterns
were built into SysQ. Interviews were administered by
trained interviewers and entered ofﬂine in real time onto
SysQ, which was installed in the laptops. Once an interview
was completed, a backup ﬁle containing all the previously
entered interview data could be generated with database
compatible format. The backup ﬁle, together with an audio
recording of the entire interview, was uploaded to a
designated server currently maintained in Beijing by a service
provider. All the uploaded ﬁles in the Beijing server were then
transferred to an Oxford server quarterly.
2.3. Statistical analysis
Statistical analyses were performed using the software
package SPSS 17.0 (SPSS Inc., Chicago, IL). We performed
logistic regression analyses to estimate the association of
dysthymia with MDD and comorbid disorders. Linear and
logistic regression models were used to determine theassociation of between measures. Coefﬁcient values, odds
ratios and 95% conﬁdence intervals were used to quantify the
strength of associations. The statistical signiﬁcance for all
tests was set at Pb0.05 and corrected where necessary for
multiple testing using a Bonferroni correction.
3. Results
3.1. Sample characteristics
From our total of 1970 cases with recurrent MDD, 354 met
criteria for dysthymia. Comparing those with and without a
diagnosis of dysthymia, we found no signiﬁcant difference in
age at interview, marital status or level of education. We then
examined the two groups for differences in the onset and
course of MDD and other potentially important risk factors,
especially personality and family history.
As seen in Table 1, patients with dysthymia had a
signiﬁcantly earlier age of onset of MDD, more depressive
episodes and a signiﬁcantly longer “longest episode” com-
pared to MDD patients without a history of dysthymia.
Dysthmic patients had signiﬁcantly higher levels of neurot-
icism, reported a signiﬁcantly greater number of stressful life
events and were likely to have one or more ﬁrst-degree
family members with a history of MDD.
3.2. Comorbidity
Wecompared lifetime prevalence rates of 6 anxiety disorders
in MDD patients with and without dysthymia (Table 2). MDD
patients with a history of dysthymia have signiﬁcantly higher
rates of panic disorder, GAD and agoraphobia, social and blood
injury phobias, and animal and situational phobias (the P-value
foranimalphobias remains signiﬁcantafter applyingaBonferroni
correction for testing nine measures (corrected threshold is
P=0.0056)).We also observed signiﬁcantly higher rates of post-
natal depression in the dysthymic patients. However there was
no signiﬁcant difference in the rates of melancholia between the
two groups.
4. Discussion
Our study addresses an issue concerning the nosology of
mood disorders in a large carefully characterized cohort of
Han Chinese women with major depression. We investigated
the extent to which patients with recurrent MDD with
dysthymia could be distinguished from those with recurrent.
Table 2
The relationship between dysthymia and nine disorders comorbid with
major depressive disorder.
Comorbid disorder P-value OR 95% CI
Agoraphobia b0.0001 1.48 1.28–1.70
Social phobia b0.0001 1.46 1.28–1.67
Animal phobia 0.0027 1.14 1.05–1.24
Situational phobia b0.0001 1.36 1.23–1.51
Blood phobia b0.0001 1.32 1.17–1.48
GAD b0.0001 1.87 1.47–2.38
Melancholia 0.64 0.93 0.69–1.25
Postnatal depression b0.0001 2.05 1.56–2.70
Panic b0.0001 2.71 1.96–3.74
GAD: Generalized anxiety disorder. OR: Odds ratio. 95% CI: 95% Conﬁdence
intervals.
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of important differences between these two groups, suggesting
that the additional diagnosis of dysthymia in cases of recurrent
MDD deﬁnes a meaningful and potentially important subtype.
Our major ﬁndings are that the cases with dysthymia have
amore severeMDD, as indexed by both the number and length
of episodes. They had greater co-morbidity with anxiety
disorders, higher neuroticism scores and a stronger familial
loading for MDD. They had experienced greater environmental
adversity as indicated by the number of reported serious life
events.
These results are broadly consistent with what has been
seen in Western studies contrasting MDD patients with and
without dysthymia and showing the former to have greater
comorbidity (Markowitz et al., 1992) and increased rates of a
family history of MDD (Klein et al., 1988, 1995; Riso et al.,
1996).
How can we explain the differences we observe between
our cases of recurrentMDDwith andwithout dysthymia? The
distinguishing features are a mixture that does not easily fall
into neat categories. The greater severity of illness and higher
familial/genetic loading might suggest a more biological
disorder (Kasch and Klein, 1996; Weissman et al., 1984).
However, no excess rates of melancholia were seen in our DD
cases, arguing against a more “biological/endogenous” pic-
ture. Furthermore, the presence of dysthymia was associated
with evidence for greater environmental adversity. The
picture of high levels of neuroticism and high comorbidity
with anxiety disorders could be interpreted as a more
“neurotic” depressive picture, consistent with the origin of
dysthymia in DSM-III with the alternative title of “depressive
neurosis.” Further studies will be needed to examine more
closely the etiologic relationship between MDD cases with
and without a history of dysthymia.
Our study beneﬁts from considering the literature on
cross-culture variation in dysthymia. A series of large
community-based studies conducted in several countries by
the World Health Organization shows substantially higher
estimates for dysthymia in high-income countries than in low
and middle-income countries (Kessler and Ustun, 2008).
Furthermore, the same studies reveal variation in severity:
whereas 21% of patients were rated as “severe” in Germany,
46% of patients in China and 59% of patients in Nigeria were so
rated. However, wherever it occurs dysthymia confers asubstantial risk of suicide (Nock et al., 2009) and considerable
impairment in functioning (Kessler and Ustun, 2008).
Part of the cross cultural variation in dysthymia can be
attributed to the different way depressive symptoms are
presented to clinicians, for instance in China somatizing
psychological stress via constructs such as neurasthenia
(Kleinman, 2004). However it should be noted that, as
Phillips et al. (2009) argue, diagnostic rates will vary if
more ﬂexible, but still rigorous, structured interviews are
used. For example, in a survey of 12% of the adult population
of China, only 15 of 16,577 individuals who completed the
Structured Clinical Interview for Diagnostic and Statistical
Manual (DSM)-IV axis I disorders met research criteria for
neurasthenia, while dysthymia emerged as the second most
common speciﬁc mood disorder (Phillips et al., 2009).
Our results should be considered in the context of several
limitations. First, all of the patients were from in-patient hospital
samples so that ourﬁndings arenot representativeof community
samples (which are likely to include less severely ill patients).
Second, our data were collected retrospectively and recall bias
will have affected results. Finally, all patientswere female, so the
applicability of our results to male patients is unknown.
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